Edition:
India

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.53USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$0.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
151,369
52-wk High
$2.70
52-wk Low
$0.45

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $19.46
Shares Outstanding(Mil.): 12.97
Dividend: --
Yield (%): --

Financials

  ABIO.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -2.05 -- --
ROI: -82.09 14.84 14.38
ROE: -82.23 16.34 16.08

BRIEF-Arca Biopharma Q1 Loss Per Share $0.20

* ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

09 May 2018

BRIEF-Arca Biopharma And Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

* ARCA BIOPHARMA AND MEDTRONIC EXTEND GENCARO CLINICAL TRIAL COLLABORATION AGREEMENT

23 Apr 2018

BRIEF-ARCA Biopharma Anticipates Meeting With FDA In Q2

* ARCA BIOPHARMA REPORTS TOPLINE PHASE 2B RESULTS FOR GENETIC-AF CLINICAL TRIAL

26 Feb 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.51 +0.21
Novartis AG (NOVN.S) CHF75.60 +0.10
Merck & Co., Inc. (MRK.N) $61.47 +0.29
Roche Holding Ltd. (ROG.S) CHF216.45 --
Roche Holding Ltd. (RO.S) CHF223.40 -0.20
Abbott Laboratories (ABT.N) $61.94 +0.19
Bayer AG (BAYGn.DE) €97.84 -1.00
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €69.27 +0.26
Eli Lilly And Co (LLY.N) $85.92 -0.15

Earnings vs. Estimates